Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Livagen

Lys-Glu-Asp-Ala, Tetrapeptide KEDA

Quick Stats
Studies 10
Trials 22
Score 2
2008 pubmed

[The effect of heavy metal ions and peptide bioregulators on the expression of chromosome fragile sites in the individuals of different age groups and breast cancer patients].

Dzhokhadze. T A TA; Ganozishvili. M N MN; Lezhava. T A TA

Key Findings

  • Young adults have higher spontaneous chromosome fragile site formation than older adults
  • Nickel, zinc, and cobalt increase fragile site expression, especially in young people
  • Livagen (and Epithalon) reduced heavy‑metal‑induced fragile sites, statistically significant only in the young group
  • Breast cancer patients showed overall higher chromosome fragility

Practical Outcomes

  • Livagen might modestly protect against heavy‑metal‑related genomic stress, but evidence is limited to young adults and small sample sizes. No clear dosage or protocol emerges, so it’s not a ready‑to‑use supplement for most biohackers. Consider it experimental and await stronger studies before adding it to a regimen.

Summary

The study looked at how heavy metals and two peptide supplements (Livagen and Epithalon) affect tiny breaks in chromosomes called fragile sites. Young people showed more natural fragile sites than older adults, and heavy metals made these breaks worse. Livagen (and Epithalon) helped lower the metal‑induced damage, but only in the young group, and the research was small and didn’t give dosing details.

Abstract

Expression rates of chromosome fragile sites in peripheral blood lymphocytes have been studied in clinically healthy individuals of different age groups (20-38 yrs and 75-86 yrs) and breast cancer patients (8 cases). In individuals with a normal check-up of different age groups the heavy metal (nickel, zinc and cobalt) ions were also examined on their influence on the expression of the fragile sites and the peptide bioregulators (Livagen and Epithalon) were tested on their ability to correct the pattern of expression. Short-term lymphocyte cultures were used as tested material. The analysis showed that the chromosomes of people from young and old age groups differ from each other by the expression pattern of fragile sites - the chromosomes of young individuals were found to be more active by spontaneous formation of fragile sites. They were also sensitive to their induction by heavy metals. Both tested bioregulators lessen heavy metals effect that was statistically reliable only for the young people group. As for the patients with breast cancer general elevated fragility of chromosomes and specific distribution of the fragile sites along the chromosomes were revealed.

Study Information

Provider

pubmed

Year

2008